|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q104074133
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010752.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q104074133
|
|
024
|
|
|
‡a
0000-0002-1484-4752
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q104074133
|
|
100
|
0 |
|
‡a
Marion G Peters
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Marion G Peters
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus
|
|
670
|
|
|
‡a
Author's Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy
|
|
670
|
|
|
‡a
Author's Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis
|
|
670
|
|
|
‡a
Author's Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women
|
|
670
|
|
|
‡a
Author's Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels
|
|
670
|
|
|
‡a
Author's Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score
|
|
670
|
|
|
‡a
Author's Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography
|
|
670
|
|
|
‡a
Author's Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
|
|
670
|
|
|
‡a
Author's Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy
|
|
670
|
|
|
‡a
Author's Contribution of liver fibrosis and microbial translocation to immune activation in HIV and HCV.
|
|
670
|
|
|
‡a
Author's Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults
|
|
670
|
|
|
‡a
Author's Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection
|
|
670
|
|
|
‡a
Author's Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
|
|
670
|
|
|
‡a
Author's Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection
|
|
670
|
|
|
‡a
Author's Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women
|
|
670
|
|
|
‡a
Author's Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus
|
|
670
|
|
|
‡a
Author's Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection
|
|
670
|
|
|
‡a
Author's Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus
|
|
670
|
|
|
‡a
Author's Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
|
|
670
|
|
|
‡a
Author's Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women
|
|
670
|
|
|
‡a
Author's Retrospective-Prospective Study of Safety and Efficacy of Sofosbuvir based Direct Acting Antivirals in HIV/HCV Coinfected Participants with Decompensated Liver Disease Pre or Post Liver Transplant
|
|
670
|
|
|
‡a
Author's Sex differences in the association of HIV infection with hepatic steatosis.
|
|
670
|
|
|
‡a
Author's Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis
|
|
909
|
|
|
‡a
(orcid) 0000000214844752
‡9
1
|
|
919
|
|
|
‡a
associationofhivhepatitis100virusandliverfibrosisseveritywiththeenhancedliverfibrosisscore
‡A
Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score
‡9
1
|
|
919
|
|
|
‡a
associationofhivinfectionhepatitis100virusinfectionandmetabolicfactorswithliverstiffnessmeasuredbytransientelastography
‡A
Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography
‡9
1
|
|
919
|
|
|
‡a
associationoftheifnl4δgallelewithimpairedspontaneousclearanceofhepatitis100virus
‡A
Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
‡9
1
|
|
919
|
|
|
‡a
suppressionofhbvbytenofovirinhbvhivcoinfectedpatientsasystematicreviewandmetaanalysis
‡A
Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis
‡9
1
|
|
919
|
|
|
‡a
sexdifferencesintheassociationofhivinfectionwithhepaticsteatosis
‡A
Sex differences in the association of HIV infection with hepatic steatosis.
‡9
1
|
|
919
|
|
|
‡a
retrospectiveprospectivestudyofsafetyandefficacyofsofosbuvirbaseddirectactingantiviralsinhivhcvcoinfectedparticipantswithdecompensatedliverdiseasepreorpostlivertransplant
‡A
Retrospective-Prospective Study of Safety and Efficacy of Sofosbuvir based Direct Acting Antivirals in HIV/HCV Coinfected Participants with Decompensated Liver Disease Pre or Post Liver Transplant
‡9
1
|
|
919
|
|
|
‡a
racialethnicdifferencesinspontaneoushcvclearanceinhivinfectedanduninfectedwomen
‡A
Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women
‡9
1
|
|
919
|
|
|
‡a
prevalenceandlongtermeffectsofocculthepatitisbvirusinfectioninhivinfectedwomen
‡A
Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
‡9
1
|
|
919
|
|
|
‡a
multiancestrygenomewideassociationstudyofspontaneousclearanceofhepatitis100virus
‡A
Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus
‡9
1
|
|
919
|
|
|
‡a
multiancestryfinemappingofinterferonlambdaandtheoutcomeofacutehepatitis100virusinfection
‡A
Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection
‡9
1
|
|
919
|
|
|
‡a
largescalecandidategeneanalysisofspontaneousclearanceofhepatitis100virus
‡A
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus
‡9
1
|
|
919
|
|
|
‡a
isolatedhepatitisbcoreantibodyisassociatedwithhivandongoingbutnotresolvedhepatitis100virusinfectioninacohortofuswomen
‡A
Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women
‡9
1
|
|
919
|
|
|
‡a
humanimmunodeficiencyvirusinfectedanduninfectedadultswithnongenotype3hepatitis100virushavelesshepaticsteatosisthanadultswithneitherinfection
‡A
Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection
‡9
1
|
|
919
|
|
|
‡a
genomewideassociationstudyofspontaneousresolutionofhepatitis100virusinfectiondatafrommultiplecohorts
‡A
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
‡9
1
|
|
919
|
|
|
‡a
correctionmultiancestryfinemappingofinterferonlambdaandtheoutcomeofacutehepatitis100virusinfection
‡A
Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection
‡9
1
|
|
919
|
|
|
‡a
controlledattenuationparameterandmagneticresonancespectroscopymeasuredliversteatosisarediscordantinobesehivinfectedadults
‡A
Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults
‡9
1
|
|
919
|
|
|
‡a
contributionofliverfibrosisandmicrobialtranslocationtoimmuneactivationinhivandhcv
‡A
Contribution of liver fibrosis and microbial translocation to immune activation in HIV and HCV.
‡9
1
|
|
919
|
|
|
‡a
chronichepatitis100virusinfectionandsubsequenthivviralloadamongwomenwithhivinitiatingantiretroviraltherapy
‡A
Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy
‡9
1
|
|
919
|
|
|
‡a
multiancestrysexstratifiedgenomewideassociationstudyofspontaneousclearanceofhepatitis100virus
‡A
A multi-ancestry sex stratified genome-wide association study of spontaneous clearance of hepatitis C virus
‡9
1
|
|
919
|
|
|
‡a
adiposetissueandmetabolicfactorsassociatedwithsteatosisinhivhcvcoinfectionhistologyversusmagneticresonancespectroscopy
‡A
Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy
‡9
1
|
|
919
|
|
|
‡a
assessingmortalityinwomenwithhepatitis100virusandhivusingindirectmarkersoffibrosis
‡A
Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis
‡9
1
|
|
919
|
|
|
‡a
associationofchronichepatitis100infectionwithtcellphenotypesinhivnegativeandhivpositivewomen
‡A
Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women
‡9
1
|
|
919
|
|
|
‡a
associationofhivhepatitis100virusandliverfibrosisseveritywithinterleukin6and100reactiveproteinlevels
‡A
Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels
‡9
1
|
|
996
|
|
|
‡2
BNF|17938917
|
|
996
|
|
|
‡2
NTA|344704629
|
|
996
|
|
|
‡2
NTA|074411837
|
|
996
|
|
|
‡2
DNB|115469885
|
|
996
|
|
|
‡2
NTA|364174730
|
|
996
|
|
|
‡2
DNB|1303953501
|
|
996
|
|
|
‡2
DNB|1029912173
|
|
996
|
|
|
‡2
NII|DA19016152
|
|
996
|
|
|
‡2
NTA|073720062
|
|
996
|
|
|
‡2
NTA|14056425X
|
|
996
|
|
|
‡2
NTA|073973572
|
|
996
|
|
|
‡2
ISNI|0000000081162175
|
|
996
|
|
|
‡2
DNB|106150378X
|
|
996
|
|
|
‡2
NTA|36455651X
|
|
996
|
|
|
‡2
DNB|173601588
|
|
996
|
|
|
‡2
NTA|07500447X
|
|
996
|
|
|
‡2
LC|n 79016533
|
|
996
|
|
|
‡2
ISNI|0000000396128369
|
|
996
|
|
|
‡2
NTA|339723688
|
|
996
|
|
|
‡2
NTA|394355156
|
|
996
|
|
|
‡2
DNB|14190562X
|
|
996
|
|
|
‡2
DNB|1214017290
|
|
996
|
|
|
‡2
NTA|163283427
|
|
996
|
|
|
‡2
CAOONL|ncf10107700
|
|
996
|
|
|
‡2
NTA|110308387
|
|
996
|
|
|
‡2
ISNI|0000000021984599
|
|
996
|
|
|
‡2
SUDOC|192843567
|
|
996
|
|
|
‡2
ISNI|0000000390993167
|
|
996
|
|
|
‡2
LC|n 2002042403
|
|
996
|
|
|
‡2
ISNI|0000000026472170
|
|
996
|
|
|
‡2
NTA|164297200
|
|
996
|
|
|
‡2
ISNI|0000000395384424
|
|
996
|
|
|
‡2
CAOONL|ncf10366313
|
|
996
|
|
|
‡2
ISNI|0000000399910698
|
|
996
|
|
|
‡2
LC|nb2008027927
|
|
996
|
|
|
‡2
NTA|072482214
|
|
996
|
|
|
‡2
NTA|073983632
|
|
996
|
|
|
‡2
LC|n 84226145
|
|
996
|
|
|
‡2
LC|no2001066323
|
|
996
|
|
|
‡2
LIH|LNB:C_b__p__e_;=CE
|
|
996
|
|
|
‡2
LC|no2016019178
|
|
996
|
|
|
‡2
RERO|A019111148
|
|
996
|
|
|
‡2
LC|n 87808881
|
|
996
|
|
|
‡2
BNF|14424946
|
|
996
|
|
|
‡2
ISNI|0000000045609603
|
|
996
|
|
|
‡2
DNB|1162300655
|
|
996
|
|
|
‡2
SUDOC|079558534
|
|
996
|
|
|
‡2
NTA|113339321
|
|
996
|
|
|
‡2
NTA|297701339
|
|
996
|
|
|
‡2
NTA|431385963
|
|
996
|
|
|
‡2
CAOONL|ncf10084378
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
